Unusual case of hyperpigmentation secondary to irinotecan
The exact mechanism is unknown, however, it has been suggested that melanocyte-stimulating hormones may be boosted by certain chemotherapy agents like doxorubicin. 3 Learning points The importance of knowledge and recognition of the oral and cutaneous adverse events in patients receiving chemotherap...
Gespeichert in:
Veröffentlicht in: | BMJ case reports 2016-10, Vol.2016, p.bcr2016217545 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The exact mechanism is unknown, however, it has been suggested that melanocyte-stimulating hormones may be boosted by certain chemotherapy agents like doxorubicin. 3 Learning points The importance of knowledge and recognition of the oral and cutaneous adverse events in patients receiving chemotherapeutics. |
---|---|
ISSN: | 1757-790X 1757-790X |
DOI: | 10.1136/bcr-2016-217545 |